NorthCrest Asset Manangement’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.44M | Buy |
|
|||||
|
2025
Q2 | $808K | Buy |
|
|||||
|
2025
Q1 | $641K | Sell |
|
|||||
|
2024
Q4 | $907K | Buy |
|
|||||
|
2024
Q3 | $593K | Buy |
|
|||||
|
2024
Q2 | $708K | Buy |
|
|||||
|
2024
Q1 | $706K | Sell |
|
|||||
|
2023
Q4 | $710K | Hold |
|
|||||
|
2023
Q3 | $606K | Hold |
|
|||||
|
2023
Q2 | $508K | Hold |
|
|||||
|
2023
Q1 | $546K | Buy |
|
|||||
|
2022
Q4 | $639K | Hold |
|
|||||
|
2022
Q3 | $568K | Hold |
|
|||||
|
2022
Q2 | $522K | Hold |
|
|||||
|
2022
Q1 | $502K | Buy |
|